Assessing clinical benefit of olaparib maintenance treatment in subgroups of patients with germline BRCA mutation (gBRCAm) and metastatic pancreatic cancer: Phase III POLO trial Meeting Abstract
| Authors: | Hochhauser, D.; Kindler, H.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Arnold, D.; Oh, D. Y.; Reinacher-Schick, A.; Tortora, G.; Algul, H.; O'Reilly, E. M.; McGuinness, D.; Cui, K.; Schlienger, K.; Locker, G.; Golan, T. |
| Abstract Title: | Assessing clinical benefit of olaparib maintenance treatment in subgroups of patients with germline BRCA mutation (gBRCAm) and metastatic pancreatic cancer: Phase III POLO trial |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S940 |
| End Page: | S941 |
| Language: | English |
| ACCESSION: | WOS:000573469102120 |
| DOI: | 10.1016/j.annonc.2020.08.2010 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1527P -- Source: Wos |
